PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.20
Bid: 18.40
Ask: 20.00
Change: -0.80 (-4.00%)
Spread: 1.60 (8.696%)
Open: 19.20
High: 19.20
Low: 19.20
Prev. Close: 20.00
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Gipave graphene asphalt trial in Kent

25 Jun 2020 07:00

RNS Number : 9790Q
Directa Plus PLC
25 June 2020
 

25 June 2020

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Gipave graphene asphalt trial in Kent

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company supplied Gipave, the Company's proprietary asphalt supermodifier, for use in a road trial in Kent, United Kingdom starting this month

 

Directa is working in collaboration with its industrial partner Iterchimica and Kent County Council, to resurface an existing road on East Hill, Dartford.

 

This follows previously announced trials in Rome, Italy, and in Oxfordshire, United Kingdom, which showed that Gipave increases the lifespan and durability of road surfaces, through the addition of a G+ graphene super modifier.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "Directa's vision is to use graphene technology to enhance existing products, to provide better outcomes for end users. Gipave is an excellent example of the products Directa produces, it allows for stronger, more durable road surfaces, and is fully recyclable. The wide adoption of Gipave road surfaces will reduce the long term financial and environmental costs of road construction for drivers and local governments alike."

-ends-

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies, Will Goode(Corporate Finance)

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASEUFLLESSELM
Date   Source Headline
15th Jan 20217:00 amRNSExercise of Options and Director / PDMR Dealing
11th Jan 20219:06 amRNSSecond Price Monitoring Extn
11th Jan 20219:00 amRNSPrice Monitoring Extension
11th Jan 20217:00 amRNSTrading Update
3rd Dec 20207:00 amRNSTrading Update
23rd Nov 20202:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSUpdate on Partner NexTech Batteries
17th Nov 20207:00 amRNSGrant of Options
26th Oct 20207:00 amRNSGraphene for Use in Lithium Sulphur Batteries
14th Oct 20207:00 amRNSSetcar Update
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 20207:00 amRNSPublication of Scientific Paper
13th Aug 20207:00 amRNSCo-Mask Anti-Viral (COVID-19) Properties Confirmed
10th Aug 20207:00 amRNSAgreement with Poltrona Frau
4th Aug 20207:00 amRNSNew San Giorgio Bridge Opens with Gipave Asphalt
30th Jul 20207:00 amRNSItalian Patent Grant for Shoe Outsoles
29th Jul 20209:00 amRNSPrice Monitoring Extension
29th Jul 20207:00 amRNSAgreement with Italdesign
28th Jul 20207:00 amRNSAppointment of Nominated Adviser and Joint Broker
27th Jul 20204:46 pmRNSTotal Voting Rights
13th Jul 20207:00 amRNSAward of Waste Management Contract
1st Jul 202011:57 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSDirector/PDMR Shareholding
26th Jun 202012:56 pmRNSResult of AGM
25th Jun 20207:00 amRNSGipave graphene asphalt trial in Kent
23rd Jun 202010:21 amRNSDirector/PDMR Shareholding
22nd Jun 20207:00 amRNSGrant of Chinese Patent
19th Jun 20207:00 amRNSLaunch of Co-Mask
1st Jun 20205:30 pmRNSPosting of Annual Report & Notice of AGM
26th May 20207:00 amRNSGrant of Key Textile Patent
21st May 20207:00 amRNSFinal Results
18th May 20207:00 amRNSTechnology Innovation Award from Frost & Sullivan
27th Apr 20207:00 amRNSEuropean Patent Grant
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSAgreement with Iterchimica
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSCovid-19 Update
13th Mar 20207:00 amRNSTrading Update
12th Feb 20207:00 amRNSEco certification of graphene printing technology
3rd Feb 20207:00 amRNSAward of Environmental services contract
27th Jan 20207:00 amRNSEU Grant for Eco-friendly G+ Printing Technology
20th Jan 20207:00 amRNSR&D Agreement with Comerio Ercole
9th Dec 20197:00 amRNSAward of Environmental Services Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.